These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Is there a drug interaction between heparin and molsidomine?]. Weimer M; Pizzulli L; Reichert H; Lüderitz B Med Klin (Munich); 1994 Jul; 89 Suppl 2():45-6. PubMed ID: 7968902 [No Abstract] [Full Text] [Related]
3. [Perioperative prevention of thromboembolism in ENT medicine]. Wilhelm T; Weber BP HNO; 1996 Jan; 44(1):31-2. PubMed ID: 8819727 [No Abstract] [Full Text] [Related]
4. The vulnerable endothelium: priming the vascular endothelium for thrombosis with unfractionated heparin: biologic plausibility for observations from the Superior Yield of the New Strategy of Enoxaparin, Revascularization and GlYcoprotein IIb/IIIa Inhibitors (SYNERGY) trial. Becker RC Am Heart J; 2005 Aug; 150(2):189-92. PubMed ID: 16086916 [No Abstract] [Full Text] [Related]
7. Current anticoagulation therapy--a GP guide. Tan KT; Lip GY Practitioner; 2004 Feb; 248(1655):87-8, 92-4, 97-8. PubMed ID: 15008109 [No Abstract] [Full Text] [Related]
8. [Advances in therapy and prevention of ischemic myocardial infarct]. Mattle HP Schweiz Med Wochenschr; 1997 Oct; 127(40):1663-6. PubMed ID: 9417588 [TBL] [Abstract][Full Text] [Related]
9. [Venous thrombosis. After heparin administration, low-molecular-weight heparin for prevention of recurrence]. MMW Fortschr Med; 2001 Apr; 143(16):56. PubMed ID: 11367997 [No Abstract] [Full Text] [Related]
10. [Percutaneous absorption of heparin: a critical review of experimental results]. Sznitowska M; Janicki S Pol Merkur Lekarski; 2000 Jan; 7(43):58-63. PubMed ID: 10765658 [TBL] [Abstract][Full Text] [Related]
11. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins]. Delsart D; Chambefort V; Decousus H Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082 [No Abstract] [Full Text] [Related]
12. [Thrombocyte control after heparin administration is essential. Thrombosis ABC, 12: Heparin-induced thrombocytopenia]. Stiefelhagen P MMW Fortschr Med; 2000 Feb; 142(8):41. PubMed ID: 10810867 [No Abstract] [Full Text] [Related]
13. [Effect of low-dosage intravenous nitrate therapy on the anticoagulant effect of heparin]. Bechtold H; Kleist P; Landgraf K; Möser K Med Klin (Munich); 1994 Jul; 89(7):360-6. PubMed ID: 7935224 [TBL] [Abstract][Full Text] [Related]
14. [Heparin in pregnant women undergoing hemodialysis. Doses according to heparin kinetic models]. Downey P; López ME Rev Med Chil; 1993 Jun; 121(6):703-4. PubMed ID: 8278710 [No Abstract] [Full Text] [Related]
15. Oral delivery of chemical conjugates of heparin and deoxycholic acid in aqueous formulation. Kim SK; Vaishali B; Lee E; Lee S; Lee YK; Kumar TS; Moon HT; Byun Y Thromb Res; 2006; 117(4):419-27. PubMed ID: 15913716 [TBL] [Abstract][Full Text] [Related]
16. [Biological monitoring and prevention of complications from antithrombotic agents]. Samama MM; Kher A Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1569-77. PubMed ID: 9092420 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of a jet injection system in administering morphine and heparin to healthy adults. Baer CL; Bennett WM; Folwick DA; Erickson RS Am J Crit Care; 1996 Jan; 5(1):42-8. PubMed ID: 8680492 [TBL] [Abstract][Full Text] [Related]
19. A bioluminescent adenosine nucleotide release assay for the diagnosis of heparin-induced thrombocytopenia. Teitel JM; Gross P; Blake P; Garvey MB Thromb Haemost; 1996 Sep; 76(3):479. PubMed ID: 8883293 [No Abstract] [Full Text] [Related]
20. [Intravenous or subcutaneous heparin. What is better in deep venous thrombosis?]. MMW Fortschr Med; 2002 Jun; 144(26):55. PubMed ID: 12154485 [No Abstract] [Full Text] [Related] [Next] [New Search]